Bo Hyun Kim

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Radiation Induced

Metastatic Colorectal Cancer

Top Venues

Journal of liver cancer

Journal of Korean medical science

This page only lists publications with an associated author ORCID identifier.

Publications

Eun Sun Jang, Hwa Young Choi, Moran Ki, Bo Hyun Kim, Kyung-Ah Kim, Sook-Hyang Jeong
Prevalence, Incidence, and Treatment Pattern of Wilson's Disease Using National Health Insurance Data From 2010-2020, Korea. Journal of Korean medical science 39 (12) (2024)
Eun Sun Jang, Hwa Young Choi, Moran Ki, Bo Hyun Kim, Kyung-Ah Kim, Sook-Hyang Jeong
Prevalence, Incidence, and Treatment Pattern of Wilson's Disease Using National Health Insurance Data From 2010-2020, Korea. Journal of Korean medical science 39 (12) (2024)
Eun Sun Jang, Hwa Young Choi, Moran Ki, Bo Hyun Kim, Kyung-Ah Kim, Sook-Hyang Jeong
Prevalence, Incidence, and Treatment Pattern of Wilson's Disease Using National Health Insurance Data From 2010-2020, Korea. Journal of Korean medical science 39 (12) (2024)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment. Journal of liver cancer 23 (1) (2023)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment. Journal of liver cancer 23 (1) (2023)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment. Journal of liver cancer 23 (1) (2023)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment. Journal of liver cancer 23 (1) (2023)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria. Journal of liver cancer 22 (1) (2022)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria. Journal of liver cancer 22 (1) (2022)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria. Journal of liver cancer 22 (1) (2022)
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria. Journal of liver cancer 22 (1) (2022)
Bo Hyun Kim, Joong-Won Park
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment. Journal of liver cancer 21 (2) (2021)
Bo Hyun Kim, Joong-Won Park
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment. Journal of liver cancer 21 (2) (2021)
Bo Hyun Kim, Joong-Won Park
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment. Journal of liver cancer 21 (2) (2021)
Bo Hyun Kim, Joong-Won Park
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment. Journal of liver cancer 21 (2) (2021)
Bo Hyun Kim
Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization? Gut and liver 14 (6) (2020)
Bo Hyun Kim, Joong-Won Park
Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation. Journal of Korean medical science 33 (45) (2018)